Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular autopsy in unexplained sudden death: a systematic review and meta-analysis of ACMG-corrected diagnostic yield, genomic architecture, and family translation. | Int J Legal Med | 2026 | 42538417 | PubTator, text mining | PubMed |
| Application of glutamine metabolism-related gene signatures in the non-invasive diagnosis of coronary artery disease: integrating bulk and single-cell transcriptomics. | J Bioenerg Biomembr | 2026 | 42530694 | PubTator, text mining | PubMed |
| Beyond the N-terminus: Emerging regulatory roles of the middle and C-terminal domains of cardiac myosin binding protein-C. | J Mol Cell Cardiol | 2026 | 42521078 | PubTator, text mining | PubMed |
| Plugging the diastolic calcium leak: MYBPC3 fragment for CPVT gene therapy. | Mol Ther | 2026 | 42508397 | PubTator, text mining | PubMed |
| Molecular Basis of Sarcomeric Variants and the Modifying Role of Non-sarcomeric Genes in Sudden Unexplained Nocturnal Death Syndrome (SUNDS). | J Mol Diagn | 2026 | 42480850 | PubTator, text mining | PubMed |
| Whole-exome sequencing identifies rare genetic variants in Egyptian patients with hypertrophic cardiomyopathy: a pilot study. | Cardiol Young | 2026 | 42478525 | PubTator, text mining | PubMed |
| Left-Dominant Arrhythmogenic Cardiomyopathy in a Young Athlete: Silent Danger on the Pitch. | JACC Case Rep | 2026 | 42460955 | PubTator, text mining | PubMed |
| Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy. | Circulation | 2026 | 42437345 | PubTator, text mining | PubMed |
| Association of TNNI3 and MYBPC3 variants with clinical phenotype and metabolic disorders in patients with hypertrophic cardiomyopathy. | BMC Cardiovasc Disord | 2026 | 42436400 | PubTator, text mining | PubMed |
| Case Report: A novel MYBPC3 gene variant in a Chinese patient with hypertrophic cardiomyopathy and apical ventricular aneurysm, with a concurrent novel KCNJ5 gene variant. | Front Cardiovasc Med | 2026 | 42428486 | PubTator, text mining | PubMed |
| The Ca2+-Sensitivity of Contraction is Increased in the Left Atrium and Left Ventricle of Patients with Ischemic Heart Failure. | bioRxiv | 2026 | 42427652 | PubTator, text mining | PubMed |
| Identification of the MYH6 c.804G>C Synonymous Variant Causing Exon Skipping in a Hypertrophic Cardiomyopathy Family. | Mol Genet Genomic Med | 2026 | 42418507 | PubTator, text mining | PubMed |
| Mavacamten shows broad benefit in human and mouse models of MYBPC3-related hypertrophic cardiomyopathy. | Nat Cardiovasc Res | 2026 | 42414613 | PubTator, text mining | PubMed |
| The Cardiac Sarcomere: From development of heritable cardiomyopathies to gene and precision therapies. | J Cardiovasc Pharmacol | 2026 | 42411452 | PubTator, text mining | PubMed |
| Identifying genetics biomarkers in correlation with pathological and PSMA PET/CT characteristics in prostate cancer. | EJNMMI Res | 2026 | 42400802 | PubTator, text mining | PubMed |
| Thick filament molecular interfaces play a critical role in the pathogenesis of hypertrophic cardiomyopathy. | Proc Natl Acad Sci U S A | 2026 | 42372158 | PubTator, text mining | PubMed |
| Pathogenic MYBPC3 missense variants alter protein-protein interactions within the sarcomere. | bioRxiv | 2026 | 42327163 | PubTator, text mining | PubMed |
| Systolic anterior motion of an anomalous papillary muscle in obstructive hypertrophic cardiomyopathy. | Cardiol Young | 2026 | 42318670 | PubTator, text mining | PubMed |
| Adeno-Associated Virus Vector Mediated Gene Therapy: A Promising Approach to Transform Hypertrophic Cardiomyopathy Treatment. | Biotechnol J | 2026 | 42307069 | PubTator, text mining | PubMed |
| The evaluation of copy number variants in an unselected population of patients with inherited cardiac conditions: the INTERACTION study. | Europace | 2026 | 42300264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=2